The Binding Nature of TGF-beta Chimeric Antigen Receptors, With Mutant Transforming Growth Factors

Authors

  • Diaman Abu Shayeb The American School of Kuwait

DOI:

https://doi.org/10.47611/jsrhs.v12i4.5282

Keywords:

TGF-b, CAR, Binding, Mutant/mutation

Abstract

A crucial aspect of the immune system is its maintenance adaptivity, this is done through the transforming growth factor beta (TGF-b). Transforming growth factors (TGF-b), which affect all cell types and regulate cell activity, are cytokines. A family of transmembrane protein kinases is how TGF-b communicates. TGF-b maintains the homeostasis of T cells in the periphery by activating TGF-b through TGF-b binding proteins in the extracellular matrix. TGF-1 can only carry out its several tasks once it transitions from a latent to an active state, during which the latency-associated peptide no longer protects the mature peptide's receptor binding site. TGF- has been proven to impair cell maintenance in the absence of this bondage, which limits its ability to promote homeostasis, differentiation, cell development, and tolerance in the face of dysregulation. Therefore, when TGF- is altered, it prevents cell cycle progression and encourages apoptosis to create tumor-suppressive effects. As a result, malignancies become more aggressive and spread more widely in their later stages.

Lab-designed receptors called chimeric antigen receptors (CAR) bind to specific proteins on cancer cells. As antigen receptors attach to transforming growth factors to create the protein TGF-b CAR, anti-immunosuppressive effects are engaged when TGF-b binds to CAR. Consequently, it possesses the question of what results from mutant TGF-b binding to TGF-b CAR? However, it is essential to determine whether the interaction is even conceivable before exploring its effects on proliferation. As a result, the question of whether TGF-b CAR binds to TGF-b mutant exists.

Downloads

Download data is not yet available.

References or Bibliography

Altman, A. “Signal Transduction Pathways in Autoimmunity.” Google Books, Google, 2002, https://books.google.jo/books?hl=en&lr=&id=UCGBmqDRPmoC&oi=fnd&pg=PA62&d q=TGF-b&ots=VG3jyPEbHh&sig=qodOuL2FevJvZgNPBZhv1L0cSRs&redir_esc=y#v=onepage&q=TGF-b&f=false.

Bennett , John E. “Chimeric Antigen Receptor.” Chimeric Antigen Receptor - an Overview | ScienceDirect Topics, 2020,

https://www.sciencedirect.com/topics/immunology-and-microbiology/chimeric-antigen-r eceptor.

Davis, D., and P. Webster. “The Social Context of Science: Cancer and the Environment: Semantic Scholar.” Undefined, 1 Jan. 1970,

https://www.semanticscholar.org/paper/The-Social-Context-of-Science%3A-Cancer-and-t he-Davis-Webster/4531f196679f745fcd19f77c47b53ec280262d86.

Doisne, Jean-Marc, et al. “Inkt Cell Development Is Orchestrated by Different Branches of TGF-Beta Signaling.” The Journal of Experimental Medicine, The Rockefeller University Press, 8 June 2009, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2715067/.

Doll, Richard. “An Epidemiological Perspective of the Biology of Cancer1.” Cancer Research, Nov. 1978, https://cancerres.aacrjournals.org/content/canres/38/11_Part_1/3573.full.pdf.

DY;, Saimaldaher ZH;Wazqar. “Relationships between Caregiving Stress, Mental Health and Physical Health in Family Caregivers of Adult Patients with Cancer: Implications for Nursing Practice.” Scandinavian Journal of Caring Sciences, U.S. National Library of Medicine, https://pubmed.ncbi.nlm.nih.gov/31750576/.

Guedan, Sonia, et al. “Engineering and Design of Chimeric Antigen Receptors.” Molecular Therapy - Methods & Clinical Development, Elsevier, 31 Dec. 2018, https://www.cell.com/molecular-therapy-family/methods/fulltext/S2329-0501(18)30133- 5.

H;, Yang EJ;Jee. “Significant Physical and Exercise-Related Variables for Exercise-Centred Lifestyle: Big Data Analysis for Gynaecological Cancer Patients.” BioMed Research International, U.S. National Library of Medicine, https://pubmed.ncbi.nlm.nih.gov/34957306/.

Hou AJ;Chang ZL;Lorenzini MH;Zah E;Chen YY; “TGF-β-Responsive Car-T Cells Promote Anti-Tumor Immune Function.” Bioengineering & Translational Medicine, U.S. National Library of Medicine, https://pubmed.ncbi.nlm.nih.gov/30065964/.

Janssens, Katrien, et al. “Transforming Growth Factor-β1 Mutations in Camurati-Engelmann Disease Lead to Increased Signaling by Altering Either Activation or Secretion of the Mutant Protein*.” Define_me, Feb. 2003, https://www.jbc.org/article/S0021-9258(19)32716-4/fulltext.

JB;, Hamilton. “Cultural Beliefs and Cancer Care: Are We Doing Everything We Can?” Cancer Nursing, U.S. National Library of Medicine, https://pubmed.ncbi.nlm.nih.gov/27922543/.June, Carl H, and Michele.

“Chimeric Antigen Receptor Therapy.” The New England Journal of Medicine, U.S. National Library of Medicine, 5 July 2018, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433347/.

Karen, et al. “Reactome: Signaling by TGFB Family Members.” Reactome Pathway Database, https://reactome.org/content/detail/R-HSA-9006936.

Kubiczkova, Lenka, et al. “TGF-β – an Excellent Servant but a Bad Master - Journal of Translational Medicine.” BioMed Central, BioMed Central, 3 Sept. 2012, https://translational-medicine.biomedcentral.com/articles/10.1186/1479-5876-10-183.

Lee, Insook, and Changseung Park. “The Mediating Effect of Social Support on Uncertainty in Illness and Quality of Life of Female Cancer Survivors: A Cross-Sectional Study - Health and Quality of Life Outcomes.” BioMed Central, BioMed Central, 19 May 2020, https://hqlo.biomedcentral.com/articles/10.1186/s12955-020-01392-2.

Lin, Jer-Sheng, and Erh-Min Lai. “Protein–Protein Interactions: Co-Immunoprecipitation.” SpringerLink, Springer New York, 1 Jan. 1970, https://link.springer.com/protocol/10.1007/978-1-4939-7033-9_17.

Lin, S Jack, et al. “The Structural Basis of TGF-β, Bone Morphogenetic Protein, and Activin Ligand Binding.” Rep, Society for Reproduction and Fertility, 1 Aug. 2006, https://rep.bioscientifica.com/view/journals/rep/132/2/1320179.xml#:~:text=Signaling%2 0by%20TGF%2D%CE%B2%20ligands,%2Dbound%20inhibitor%20(BAMBI).

Lobo, Neethan A. “The Biology of Cancer Stem Cells - Cytothesis.us.” The Biology of Cancer Stem Cells , July 2007,http://www.cytothesis.us/3.0/The-Biology-of-Cancer-Stem-Cells.pdf.

Neethan Lobo, Co-Founder at Onena Medicines in Spain. As well as Yohi Shimono, Love, Richard L. “Improving Cancer Outcomes In Low- and Middle-Income Countries.” Journal of Global Oncology, https://ascopubs.org/doi/full/10.1200/JGO.19.00297.

Maghsoodi, Soodeh. “Health- Oriented Lifestyle of Cancer Patients and the Affecting Factors in Iran: A Case Study of the Cancer Patients in Kerman City.” Basic & Clinical Cancer Research, Nov. 2017, https://bccr.tums.ac.ir/index.php/bccrj/article/view/233.

Maria Chiara Maiuri, Guido Kroemer, Essential Role for Oxidative Phosphorylation in Cancer Progression, Cell Metabolism, Volume 21, Issue 1, 2015, Pages 11-12, ISSN 1550-4131, https://doi.org/10.1016/j.cmet.2014.12.013.

Martire, Lynn M. “Involving Family in Psychosocial Interventions for Chronic Illness - JSTOR.” APAPsych Net, https://www.jstor.org/stable/20183169.

Miller, Written by Ashleigh. “Co-Immunoprecipitation Protocol: 9 Easy Steps to Co-Ips.” Bitesize Bio, 2 Feb. 2022,

https://bitesizebio.com/19773/co-immunoprecipitation-protocol-guide/.

Mitchell, J. M. “The Effect of Chronic Disease on Work Behavior over the Life Cycle.” Southern Economic Journal, 1990, http://www.ijdcr.ca/VOL03_02_CAN/articles/crotty.shtml.

Noh KE;Lee JH;Choi SY;Jung NC;Nam JH;Oh JS;Song JY;Seo HG;Wang Y;Lee HS;Lim DS; “TGF-β/IL-7 Chimeric Switch Receptor-Expressing Car-T Cells Inhibit Recurrence of CD19-Positive B Cell Lymphoma.” International Journal of Molecular Sciences, U.S. National Library of Medicine, 2022, https://pubmed.ncbi.nlm.nih.gov/34445415/.

Oh, Soyoung A, and Ming O Li. “TGF-β: Guardian of T Cell Function.” Journal of Immunology (Baltimore, Md. : 1950), U.S. National Library of Medicine, 15 Oct. 2013, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3856438/#:~:text=In%20the%20peripher y%2C%20TGF%2D%CE%B2,autoreactive%2Fhigh%20affinity%20T%20cells.

Pinkaew, Decha, et al. “Fortilin Interacts with TGF-β1 and Prevents TGF-β Receptor Activation.” Nature News, Nature Publishing Group, 23 Feb. 2022, https://www.nature.com/articles/s42003-022-03112-6.

Paolo E. Porporato, Valéry L. Payen, Jhudit Pérez-Escuredo, Christophe J. De Saedeleer, Pierre Danhier, Tamara Copetti, Suveera Dhup, Morgane Tardy, Thibaut Vazeille, Caroline Bouzin, Olivier Feron, Carine Michiels, Bernard Gallez, Pierre Sonveaux, A Mitochondrial Switch Promotes Tumor Metastasis, Cell Reports, Volume 8, Issue 3, 2014, Pages 754-766, ISSN 2211-1247, https://doi.org/10.1016/j.celrep.2014.06.043.

“Physical Health and Mental Health.” Mental Health Foundation, https://www.mentalhealth.org.uk/explore-mental-health/a-z-topics/physical-health-and-m ental-health.

Pierre Blanchard, Anne W.M. Lee, Alexandra Carmel, Ng Wai Tong, Jun Ma, Anthony T.C. Chan, Ruey Long Hong, Ming-Yuan Chen, Lei Chen, Wen-Fei Li, Pei-Yu Huang, Dora L.W. Kwong, Sharon S.X. Poh, Roger Ngan, Hai-Qiang Mai, Camille Ollivier, George Fountzilas, Li Zhang, Jean Bourhis, Anne Aupérin, Benjamin Lacas, Jean-Pierre Pignon, Anne Aupérin, Pierre Blanchard, Ellen Benhamou, Jean Bourhis, Alexandra Carmel, Somvilai Chakrabandhu, Anthony TC Chan, Lei Chen, Ming-Yuan Chen, Qiu-Yan Chen, Yong Chen, Richard J Chappell, Horace Choi, Daniel TT Chua, Melvin Lee Kiang Chua, George Fountzilas, Julian Higgins, Ming-Huang Hong, Ruey-Long Hong, Pei-Yu Huang, Edwin Pun Hui, C.F. Hsiao, Michael Kam, Georgia Angeliki Koliou, Dora LW Kwong, Benjamin Lacas, Shu-Chuan Lai, Ka On Lam, Michael L LeBlanc, Anne WM Lee, Ho Fun Victor Lee, Wen Fei Li, Brigette Ma, Jun Ma, Hai-Qiang Mai, Frankie Mo, James Moon, Wai Tong Ng, Roger Ngan, Camille Ollivier, Brian O'Sullivan, Claire Petit, Jean Pierre Pignon, Sharon X. Poh, Gerta Rücker, Jonathan Sham, Yoke Lim Soong, Ying Sun, Terence Tan, Lin-Quan Tang, Yuk Tung, Joseph Wee, Xuang Wu, Tingting Xu, Li Zhang, Yuan Zhang, Guopei Zhu, Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patients, Clinical and Translational Radiation Oncology, Volume 32, 2022, Pages 59-68, ISSN 2405-6308, https://doi.org/10.1016/j.ctro.2021.11.007.

R;, Arora B;Tandon R;Attri P;Bhatia. “Chemical Crosslinking: Role in Protein and Peptide Science.” Current Protein & Peptide Science, U.S. National Library of Medicine, 2017, https://pubmed.ncbi.nlm.nih.gov/27455969/.

Ralph J. DeBerardinis, Julian J. Lum, Georgia Hatzivassiliou, Craig B. Thompson,The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation, Cell Metabolism,Volume 7, Issue 1,2008,Pages 11-20,ISSN 1550-4131,https://doi.org/10.1016/j.cmet.2007.10.002.

Ricardo Cruz-Acuña, Gordana Vunjak-Novakovic, Jason A. Burdick, Anil K. Rustgi, Emerging technologies provide insights on cancer extracellular matrix biology and therapeutics, iScience, Volume 24, Issue 5, 2021, 102475, ISSN 2589-0042, https://doi.org/10.1016/j.isci.2021.102475.

Rızalar, Selda, et al. “University Students' Awareness of Breast and Cervical Cancers: A Comparison of Two Countries and Two Different Cultures.” The Journal of Breast Health, Turkish Federation of Breast Diseases Associations, 1 Apr. 2017, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5381679/.

RJ;, Curran KJ;Pegram HJ;Brentjens. “Chimeric Antigen Receptors for T Cell Immunotherapy: Current Understanding and Future Directions.” The Journal of Gene Medicine, U.S. National Library of Medicine, 2012, https://pubmed.ncbi.nlm.nih.gov/22262649/.

Ruivo, Carolina F. “The Biology of Cancer Exosomes: Insights and New Perspectives.” Cancer Research, Nov. 2017, https://cancerres.aacrjournals.org/content/canres/77/23/6480.full.pdf.

TGF-Beta Signaling Pathway | Sino Biological. https://www.sinobiological.com/pathways/tgf-beta-pathway.

Van Zutphen, Moniek, et al. “Colorectal Cancer Survivors Only Marginally Change Their Overall Lifestyle in the First 2 Years Following Diagnosis.” Journal of Cancer Survivorship : Research and Practice, Springer US, Dec. 2019, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6881417/.

Wang, Yi-Wen, et al. “Sirna-Targeting Transforming Growth Factor-β Type I Receptor Reduces Wound Scarring and Extracellular Matrix Deposition of Scar Tissue.” Journal of Investigative Dermatology, Elsevier, 8 Dec. 2015, https://www.sciencedirect.com/science/article/pii/S0022202X15368767.

Weinberg , Robert A. “The Biology of Cancer.” Garland Science, 2007, http://web.thu.edu.tw/cphu/www/cancer_biology/download/Ch_8_pRb_and_Control_of_ the_Cell_Cycle_Clock.pdf.

Yeo, Michele, and Susan Sawyer. “Chronic Illness and Disability.” BMJ (Clinical Research Ed.), BMJ Publishing Group Ltd., 26 Mar. 2005, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC555640/.

Zuckerman, Brian L., et al. “Clinical Interpretation of Variants in Cancer (CIViC).” Informatics Technologies for Cancer Research (ITCR) Case Study Report, Institute for Defense Analyses, 2018, pp. 15–20, http://www.jstor.org/stable/resrep36489.6.

Published

11-30-2023

How to Cite

Abu Shayeb, D. (2023). The Binding Nature of TGF-beta Chimeric Antigen Receptors, With Mutant Transforming Growth Factors. Journal of Student Research, 12(4). https://doi.org/10.47611/jsrhs.v12i4.5282

Issue

Section

AP Capstone™ Research